Study finds dosing strategy may affect immunotherapy outcomes
Fitbit user data show slight increase in sleep duration in US during COVID-19 pandemic
14 June 2021‘Ice’ flavored e-cig use may be linked to nicotine dependence among the young
14 June 2021Study finds dosing strategy may affect immunotherapy outcomes
Overweight cancer patients receiving immunotherapy treatments live more than twice as long as lighter patients, but only when dosing is weight-based, according to a study by cancer researchers at UT Southwestern Medical Center.
